Genvoya tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3PVY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,176
Award facts
- Contract value 100% obligated
- $18,175.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,175.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Genvoya tablets (30-count bottles) with a completion date of November 25, 2025. This non-set-aside contract represents a small delivery against AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. Genvoya is an antiretroviral medication used in HIV treatment, reflecting the Department of Defense's ongoing medical supply requirements across its healthcare systems serving military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and related healthcare commodities to support military healthcare programs worldwide. The vendor's federal contracting history demonstrates consistent competitive success in supplying diverse pharmaceutical products to Defense Health Agency and other government healthcare systems, positioning the company as a critical pharmaceutical distributor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F3PVY?
SPE2DR26F3PVY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F3PVY worth?
The government has obligated $18,176 on SPE2DR26F3PVY.
Is contract SPE2DR26F3PVY an order under another contract?
Yes. SPE2DR26F3PVY is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3PVY competed?
The extent of competition for SPE2DR26F3PVY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award